Helping to commercialise research from the University of Cambridge for the benefit of society worldwide.
Cambridge Enterprise is the commercialisation arm of the University of Cambridge.
At Cambridge Enterprise, we help University of Cambridge members create beneficial impact from their research and expertise that can change the world, through academic consultancy, intellectual property management, development and licensing, venture building, venture funding and convening and connecting the wider Cambridge innovation ecosystem.
Our success is measured in the success of our University partners as they bring their work to market, be it ground-breaking stem cell research, critical suspension technology used in Formula 1 racing, or a flower seed mix to enable bees to flourish and crops grow. We’re here to make the world a better place by helping to create a legacy of products, services and advice that benefit not just the University and the UK, but everyone.
Technology transfer, University consulting, Innovation, Commercialisation, Consultancy, University Seed Funding, Technology licensing, Spinout company formation, Research commercialisation, Intellectual property, Entrepreneurship, Knowledge transfer, Knowledge exchange, Academic consultancy, and Research impact
Home – Cambridge Enterprise
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Animorph Co-op edtech, it services, Software Development | Other 31 Jul 2024 | | ||
ASTP edtech | Other 5 Sep 2024 | | ||
Keepit it services | Other 28 Aug 2024 | | ||
Neuro XR it services, Software Development | Other 10 Aug 2024 | | ||
Redstone Venture Capital and Private Equity Principals | Other 31 May 2024 | | ||
Exiger fintech, regtech, Software Development | Other 28 Jul 2024 | | ||
BSI International Trade and Development | Other 28 Jul 2024 | | ||
Altair Software Development | Other 5 Aug 2024 | | ||
CellCentric biotech, deeptech | Other 24 Jul 2024 | | ||
Puraffinity greentech, biotech, cleantech, Environmental Services, water management, manufacturing, deeptech | Other 31 May 2024 | |